We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+11.27%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$15.6M
Cap. Flow
+$220M
Cap. Flow %
163.5%
Top 10 Hldgs %
31.52%
Holding
253
New
80
Increased
47
Reduced
36
Closed
74

Top Buys

1
HUM icon
Humana
HUM
+$4.21M
2
AMGN icon
Amgen
AMGN
+$3.4M
3
EHC icon
Encompass Health
EHC
+$3.34M
4
SLNO
Soleno Therapeutics
SLNO
+$3.29M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.9M

Top Sells

1
CNC icon
Centene
CNC
+$10.3M
2
UNH icon
UnitedHealth
UNH
+$4.9M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.17M
4
IBIT icon
iShares Bitcoin Trust
IBIT
+$3M
5
CON
Concentra Group Holdings
CON
+$2.39M

Sector Composition

1 Healthcare 51.79%
2 Financials 16.59%
3 Materials 5%
4 Technology 2.34%
5 Energy 1.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALT icon
51
PUT
Altimmune
ALT
$558M
$792K 0.59%
+19,081
New +$103K
GILD icon
52
Gilead Sciences
GILD
$167B
$767K 0.57%
+6,919
New +$736K
AFRM icon
53
Affirm
AFRM
$25.5B
$760K 0.56%
+10,989
New +$570K
ARGX icon
54
argenx
ARGX
$53.8B
$759K 0.56%
1,377
-1,389
-50% -$806K
IMCR icon
55
Immunocore
IMCR
$1.78B
$754K 0.56%
24,038
+1,708
+8% +$53.1K
CASH icon
56
Pathward Financial
CASH
$1.89B
$743K 0.55%
+9,389
New +$718K
HCC icon
57
Warrior Met Coal
HCC
$4.17B
$742K 0.55%
16,199
+10,221
+171% +$474K
CVE icon
58
Cenovus Energy
CVE
$52.1B
$741K 0.55%
54,517
-14,275
-21% -$185K
BPOP icon
59
Popular Inc
BPOP
$11.1B
$724K 0.54%
+6,566
New +$648K
HOOD icon
60
Robinhood
HOOD
$89.7B
$706K 0.52%
7,545
-2,074
-22% -$123K
LOB icon
61
Live Oak Bancshares
LOB
$1.97B
$699K 0.52%
+23,473
New +$633K
ATYR
62
PUT
aTyr Pharma
ATYR
$50M
$698K 0.52%
64,421
+64,394
+238,496% +$253K
REGN icon
63
Regeneron Pharmaceuticals
REGN
$70.9B
$687K 0.51%
1,309
-5,671
-81% -$3.17M
RVMD icon
64
Revolution Medicines
RVMD
$39.6B
$671K 0.5%
+18,239
New +$701K
RDNT icon
65
RadNet
RDNT
$4.89B
$667K 0.49%
+11,724
New +$644K
SMBK icon
66
SmartFinancial
SMBK
$823M
$663K 0.49%
19,636
+6,157
+46% +$190K
COGT icon
67
Cogent Biosciences
COGT
$6.68B
$648K 0.48%
90,211
– –
FISV
68
Fiserv Inc
FISV
$27B
$647K 0.48%
+3,752
New +$680K
SCHW
69
Charles Schwab
SCHW
$177B
$643K 0.48%
+7,043
New +$590K
CFG icon
70
Citizens Financial Group
CFG
$30.6B
$630K 0.47%
+14,082
New +$554K
FLUT icon
71
Flutter Entertainment
FLUT
$18.5B
$624K 0.46%
2,183
+714
+49% +$175K
PIPR icon
72
Piper Sandler
PIPR
$5.16B
$605K 0.45%
+8,704
New +$542K
TGB
73
Trekor Metals
TGB
$2.48B
$532K 0.39%
168,901
+63,132
+60% +$148K
MYFW icon
74
First Western Financial
MYFW
$323M
$528K 0.39%
23,406
+6,022
+35% +$124K
SBCF icon
75
Seacoast Banking Corp of Florida
SBCF
$3.3B
$519K 0.38%
+18,777
New +$464K
1 2
3
4 5

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Persistent Asset Partners held 253 positions worth $135M, up 13% from $119M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Persistent Asset Partners deployed $220M of net new capital in Q2 2025, opening 80 new positions and adding to 47 existing holdings. Its largest new stake was Amgen: 12,000 shares worth $3.35M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 61% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $3.17M trimmed.

  • Persistent Asset Partners's largest Q2 2025 buy was Amgen: 12,000 shares worth $3.35M.
  • Persistent Asset Partners added most to Humana in Q2 2025, an estimated $4.21M increase.
  • Persistent Asset Partners's biggest Q2 2025 reduction was Regeneron Pharmaceuticals, cutting an estimated $3.17M.
  • Persistent Asset Partners fully exited Centene in Q2 2025, selling an estimated $10.3M.
  • Persistent Asset Partners's ten largest holdings make up 32% of its $135M portfolio in Q2 2025.
  • Persistent Asset Partners opened 80 new positions and closed 74 in Q2 2025.
  • Persistent Asset Partners's portfolio value rose 13% quarter-over-quarter to $135M.

Based on Persistent Asset Partners's 13F filing for Q2 2025, filed 11 Aug 2025.